https://www.precisionbusinessinsights.com/market-reports/global-cancer-biomarker-testing-market
Cancer Biomarker Testing Market was valued at USD 10.42 billion in 2022 and is anticipated to grow at USD 20.59 billion by 2029 recording a CAGR of 15.4% during the forecast period 2023-2029. The cancer biomarker test market is driven by rising prevalence of cancer worldwide. World Health Organization (WHO) stated that cancer is one of the leading causes of mortality and morbidity worldwide, with approximately 14 Mn new cases in 2012.
Copyright 2019 © P-tweets Refunds